Latest Insmed Incorporated (INSM) News on July 7, 2024
MT Newswires
4 days ago
Insmed Presenting More Positive Data for Prospective Drug Treatment for Bronchiectasis This Week
MT Newswires
16 days ago
Evercore ISI Boosts Price Target on Insmed to $75 From $42, Maintains Outperform Rating
MT Newswires
17 days ago
JPMorgan Raises Insmed's Price Target to $72 From $55, Maintains Overweight Rating
MT Newswires
24 days ago
Insmed Insider Sold Shares Worth $1,271,700, According to a Recent SEC Filing
Business Insider
a month ago
US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia
Investor's Business Daily
a month ago
Dow Jones Futures Due; Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events
The Wall Street Journal
a month ago
European Union Vote Delivers Shift to Right, in Blow to French and German Governments
MT Newswires
a month ago
Insmed Insider Sold Shares Worth $3,043,150, According to a Recent SEC Filing
MT Newswires
a month ago
Stifel Adjusts Price Target on Insmed to $74 From $67, Maintains Buy Rating
PR Newswire
a month ago
Insmed To Present at the Goldman Sachs 45th Annual Global Healthcare Conference
MT Newswires
a month ago
Stifel Adjusts Price Target on Insmed to $67 From $39, Maintains Buy Rating
MT Newswires
a month ago
Insmed Insider Sold Shares Worth $1,362,075, According to a Recent SEC Filing
MT Newswires
a month ago
Insmed Insider Sold Shares Worth $6,316,579, According to a Recent SEC Filing
MT Newswires
a month ago
Insmed Insider Sold Shares Worth $12,064,607, According to a Recent SEC Filing
MT Newswires
a month ago
Insmed Insider Sold Shares Worth $2,215,081, According to a Recent SEC Filing
MT Newswires
a month ago
Wolfe Research Adjusts Price Target on Insmed to $54 From $42, Maintains Outperform Rating
MT Newswires
a month ago
Morgan Stanley Adjusts Price Target on Insmed to $60 From $43, Maintains Overweight Rating
MT Newswires
a month ago
Goldman Sachs Adjusts Insmed Price Target to $74 From $49, Maintains Buy Rating
Investor's Business Daily
a month ago
The Next Humira? Insmed Catapults 119% On Its 'Very Attractive' Opportunity In Lung Disease.
Barrons.com
a month ago
Insmed Stock Surges on Trial Win for Lung-Condition Drug. ‘We Hit the Mark,’ CEO Says.
Associated Press Finance
a month ago
Insmed, Agios rise; DraftKings, Atlantica fall, Tuesday, 5/28/2024
GuruFocus.com
2 months ago
Insider Sale: Chief Medical Officer Martina Flammer Sells Shares of Insmed Inc (INSM)
MT Newswires
2 months ago
Goldman Sachs Adjusts Price Target on Insmed to $49 From $40, Maintains Buy Rating
Simply Wall St.
2 months ago
Insmed Incorporated (NASDAQ:INSM) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
GuruFocus.com
2 months ago
Insmed Inc (INSM) Reports Q1 2024 Earnings: Misses EPS Estimates, Revenue Grows Amidst Clinical ...
MT Newswires
2 months ago
Mizuho Securities Raises Price Target on Insmed to $36 From $35, Keeps Buy Rating
Simply Wall St.
2 months ago
Insmed First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
PR Newswire
2 months ago
Insmed Reports First-Quarter 2024 Financial Results and Provides Business Update
Simply Wall St.
2 months ago
We Think Some Shareholders May Hesitate To Increase Insmed Incorporated's (NASDAQ:INSM) CEO Compensation
PR Newswire
2 months ago
Insmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024
PR Newswire
4 months ago
Insmed Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Business Update
Simply Wall St.
5 months ago
Despite shrinking by US$218m in the past week, ATI (NYSE:ATI) shareholders are still up 127% over 3 years
Simply Wall St.
5 months ago
Is There An Opportunity With Olin Corporation's (NYSE:OLN) 25% Undervaluation?
Associated Press Finance
5 months ago
Intel, KLA fall; American Express, Olin rise, Friday, 1/26/2024
